{"title":"Calciumkanle: Tabelle I","body":"Calciumkanäle<\/STRONG>\n

<\/P>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n
\nCa2+<\/SUP>-Kanal-Klasse\n<\/TD>\n\nCa2+<\/SUP>-Kanal-Typ\n<\/TD>\n\nSpezifische Blocker\n<\/TD>\n<\/TR>\n
\nHVA Ca2+<\/SUP>-Kanäle\n<\/TD>\n\n<\/TD>\n\n<\/TD>\n<\/TR>\n
\nS\n<\/TD>\n\nL\n<\/TD>\n\nDihydropyridine\n<\/TD>\n<\/TR>\n
\nA \n<\/TD>\n\nP\/Q\n<\/TD>\n\nω-Agatoxin IVA\n<\/TD>\n<\/TR>\n
\nB \n<\/TD>\n\nN\n<\/TD>\n\nω-Conotoxin GVIA\n<\/TD>\n<\/TR>\n
\nC\n<\/TD>\n\nL\n<\/TD>\n\nDihydropyridine\n<\/TD>\n<\/TR>\n
\nD\n<\/TD>\n\nL\n<\/TD>\n\nDihydropyridine\n<\/TD>\n<\/TR>\n
\nE\n<\/TD>\n\nR\n<\/TD>\n\nnoch nicht bekannt\n<\/TD>\n<\/TR>\n
\nF\n<\/TD>\n\nL\n<\/TD>\n\nDihydropyridine\n<\/TD>\n<\/TR>\n
\nLVA Ca2+<\/SUP>-Kanäle\n<\/TD>\n\n<\/TD>\n\n<\/TD>\n<\/TR>\n
\nG\n<\/TD>\n\nT\n<\/TD>\n\nMibefradil\n<\/TD>\n<\/TR>\n
\nH\n<\/TD>\n\nT\n<\/TD>\n\nMibefradil\n<\/TD>\n<\/TR>\n
\nI\n<\/TD>\n\nT\n<\/TD>\n\nMibefradil(?)\n<\/TD>\n<\/TR>\n\n<\/TABLE><\/TD><\/TR><\/TABLE>"}